|
TSO (Details Textual)
|
1 Months Ended | 3 Months Ended | 81 Months Ended | 1 Months Ended | 3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Feb. 22, 2013
|
Mar. 31, 2013
USD ($)
|
Mar. 31, 2012
USD ($)
|
Mar. 31, 2013
USD ($)
|
Feb. 22, 2013
Research and Development Arrangement [Member]
USD ($)
|
Feb. 22, 2013
Research and Development Arrangement [Member]
EUR (€)
|
Mar. 31, 2013
Research and Development Arrangement [Member]
USD ($)
|
Feb. 22, 2013
Joint Ownership and Exclusive License Agreement FU Berlin [Member]
USD ($)
|
Feb. 22, 2013
Joint Ownership and Exclusive License Agreement FU Berlin [Member]
EUR (€)
|
Feb. 22, 2013
Joint Ownership and Exclusive License Agreement FU Berlin [Member]
Maximum [Member]
|
Feb. 22, 2013
Joint Ownership and Exclusive License Agreement FU Berlin [Member]
Minimum [Member]
|
Feb. 22, 2013
License and Sublicense Agreement with Ovamed GmbH [Member]
USD ($)
|
Feb. 22, 2013
License and Sublicense Agreement with Ovamed GmbH [Member]
EUR (€)
|
Feb. 22, 2013
License and Sublicense Agreement with Ovamed GmbH [Member]
Maximum [Member]
|
Feb. 22, 2013
License and Sublicense Agreement with Ovamed GmbH [Member]
Minimum [Member]
|
|
| TSO (Textual) [Abstract] | |||||||||||||||
| Expected project duration under Research Agreement | 4 years | 4 years | |||||||||||||
| Research and development expense | $ 5,974,000 | $ 4,581,000 | $ 47,983,000 | $ 843,000 | € 648,000 | $ 22,000 | |||||||||
| Written notice period under Research Agreement Termination | 3 months | 3 months | |||||||||||||
| Potential milestone payments based primarily on the achievement of clinical development and regulatory milestones | 4,982,000 | 3,830,000 | |||||||||||||
| Percentage of royalty on net sales of products range | 2.50% | 1.00% | 2.50% | 1.00% | |||||||||||
| Maximum potential payment based on achievement of regulatory milestones, | $ 1,333,000 | € 1,025,000 | |||||||||||||
| Right Interest in Joint Intellectual Property | 10.00% | ||||||||||||||
| Notice period to cure termination due to breach | 60 days | ||||||||||||||
| Period of notice for termination of Joint Ownership and exclusive license agreement | 60 days | ||||||||||||||
| Period of Written notice for termination of Joint Ownership and exclusive license agreement | 180 days | ||||||||||||||